No membership fee required. No yearly fees. Only pay for what you want. Cancel anytime.

Apexion Health CJC-1295 + Ipamorelin treatment vial
LONGEVITYGHRH STACK

MONTHLY SUPPLY · INJECTION

CJC-1295 + IPAMORELIN

TREATMENT

Growth hormone secretagogue combination that amplifies pulsatile GH release for lean muscle support, recovery, and deep sleep quality.

SUPPORT

CJC-1295 + Ipamorelin is a combination of two growth hormone secretagogues that work together to enhance growth hormone release. CJC-1295 provides sustained GH release through its extended half-life, while Ipamorelin delivers clean, pulsatile GH spikes without significantly affecting cortisol or prolactin levels — creating a more natural and effective GH stimulation pattern.

Shop Now

Lab-Tested · Physician-Supervised · Discreet Delivery

Apexion Health — LONGEVITY

SUSTAINED AND PULSATILE GROWTH HORMONE RELEASE.

Traditional GH secretion occurs in pulses, particularly during deep sleep. CJC-1295 is a modified form of growth hormone-releasing hormone (GHRH) with an extended half-life that provides more sustained GH stimulation, while Ipamorelin is a selective GH secretagogue that promotes pulsatile GH release with minimal impact on cortisol and prolactin. Together, they create a GH secretion pattern that more closely mimics the body's natural rhythm — providing both baseline support and the therapeutic pulses associated with lean muscle growth, fat metabolism, and recovery.

Clinical Benefits

CJC-1295 + IPAMORELIN SUPPORTS YOUR HEALTH AT THE CELLULAR LEVEL

  1. 01.

    COMBINES SUSTAINED AND PULSATILE GH RELEASE PATTERNS

  2. 02.

    PROMOTES LEAN MUSCLE GROWTH AND FAT METABOLISM

  3. 03.

    SUPPORTS DEEP SLEEP QUALITY AND OVERNIGHT RECOVERY

  4. 04.

    MINIMAL IMPACT ON CORTISOL AND PROLACTIN LEVELS

  5. 05.

    PHYSICIAN-SUPERVISED GROWTH HORMONE SECRETAGOGUE COMBINATION

Shop Now

Clinical Evidence

How It Works in the Body

01 — Dose & Efficacy

GH Secretagogue Synergy

GH Pulse Amplitude (Ipa) Clean, selective stimulation60%
GH Baseline Elevation (CJC) Sustained GHRH receptor activation50%
IGF-1 Increase Downstream anabolic mediator45%

Teichman et al., Clin Interv Aging 2006; Sigalos et al., Rev Urol 2017

02 — Hormone Panel

GH Secretagogue Selectivity Profiles

MarkerWithoutWith Treatment
CJC-1295 — Half-lifeDays
GHRH: ~12 min
CJC-1295: ~6–8 daysExtended
Ipamorelin — GH Selectivity—
Non-selective GHS
Highly selective for GHCleaner
Ipamorelin — Cortisol—
GHRP-6: ↑ cortisol
Ipamorelin: minimal ΔPreserved
Ipamorelin — Prolactin—
GHRP-2: ↑ prolactin
Ipamorelin: minimal ΔPreserved

Physiological GH pattern: sustained baseline + clean pulses

CJC-1295 (modified GHRH with D-Ala² substitution and lysine linker for albumin binding) provides prolonged GHRH tone. Ipamorelin selectively triggers GH pulses without the cortisol/prolactin spillover of earlier GHS peptides. Together they mimic endogenous GH secretory dynamics.

Teichman et al., Clin Interv Aging 2006; Johansen et al., J Clin Endocrinol Metab 2001; Raun et al., Eur J Endocrinol 1998

03 — Protocol

CJC-1295 + Ipamorelin Protocol

BaselinePre-treatment
  • ›IGF-1 level (age-adjusted)
  • ›Fasting glucose & HbA1c
  • ›Body composition & sleep quality
InitiationWeeks 1–4
  • ›CJC-1295 1–2 mg + Ipamorelin 200–300 mcg SC at bedtime
  • ›IGF-1 at 2–4 weeks
  • ›Sleep & recovery tracking
OptimizationMonth 2+
  • ›Titrate to target IGF-1 (upper tertile, age-adjusted)
  • ›Body composition q3 months
  • ›Cycle: 5 days on / 2 off recommended

Nighttime dosing aligns with natural GH pulsatility

Inject 60–90 min after last meal, at bedtime. Natural GH secretion peaks during slow-wave sleep — dosing before sleep amplifies this endogenous rhythm. Fasted state improves GH response. Cycling (5 on / 2 off) may reduce tachyphylaxis risk.

All protocols physician-supervised and adjusted per individual labs.